Seres Therapeutics, Inc., a company specializing in microbiome therapeutics, announced on Monday that they have appointed Marella Thorell as their new Chief Financial Officer. Taking up her new role on March 25, Thorell will succeed the current CFO, David Arkowitz, who is retiring.
Before joining Seres, Thorell held executive roles at various companies, including Evelo Biosciences, Centessa Pharmaceuticals, Palladio Biosciences, and Realm Therapeutics.
